Elite Pharmaceuticals outlines ropinirole launch next month and targets 5% to 10% of its $12M market (OTCMKTS:ELTP)June 30, 2026
Share Facebook Twitter LinkedIn Pinterest Email Calibre Mining Non-GAAP EPS of $0.05, revenue of $143.88M
Elite Pharmaceuticals outlines ropinirole launch next month and targets 5% to 10% of its $12M market (OTCMKTS:ELTP)June 30, 2026